|
|
|
| 基本情報 |
|
| 氏名 |
佐伯 亘平 |
| 氏名（カナ） |
ｻｴｷ ｺｳﾍｲ |
| 氏名（英語） |
Saeki Kohei |
| 所属 |
獣医学部 獣医学科 |
| 職名 |
准教授 |
| researchmap研究者コード |
R000007576 |
| researchmap機関 |
岡山理科大学 |
Anti-tumour efficacy of etoposide alone and in combination with piroxicam against canine osteosarcoma in a xenograft model.
[S M Ong,K Saeki,M K Kok,Y Tanaka,N Choisunirachon,R Yoshitake,R Nishimura,T Nakagawa]
|
 |
Osteosarcoma (OSA) in dogs is locally invasive and highly malignant. Distant metastasis is the most common cause of death. To date, the survival rate in dogs with OSA remains poor. The cytotoxic effects of etoposide against canine OSA cell lines, either alone or in combination with piroxicam, have been previously demonstrated in vitro. The aim of this study was to evaluate the anti-tumour effect of etoposide alone and in combination with piroxicam on canine OSA using murine models. Etoposide single agent treatment significantly delayed tumour progression with a marked reduction in Ki-67 immunoreactivity in tumour tissue. Concomitant treatment with piroxicam did not enhance the anti-tumour efficacy of etoposide. Etoposide single agent treatment and combination treatment with piroxicam down-regulated survivin expression, but was not followed by increased apoptotic activity. These findings indicate that etoposide might be a promising novel therapeutic for canine OSA. Further investigations into its potential for clinical application in veterinary oncology are warranted.
Research in veterinary science
|
